Related Experiment Videos
Insulin analogues: new agents for improving glycemic control
J R White1, R K Campbell, I Hirsch
1Washington State University, College of Pharmacy, Spokane, USA. whitej@wsu.edu
Postgraduate Medicine
|February 1, 1997
Summary
Strict glycemic control is crucial for managing diabetes mellitus complications. Newer insulin analogues offer improved pharmacokinetic profiles for better insulin therapy outcomes.
Area of Science:
- Endocrinology
- Pharmacology
Background:
- Effective diabetes mellitus management requires controlling blood glucose levels.
- Strict glycemic control is essential for preventing chronic diabetes complications.
Purpose of the Study:
- To evaluate the role of strict glycemic control in diabetes management.
- To discuss the limitations of traditional insulin therapy and the potential of new insulin analogues.
Main Methods:
- Review of recent studies on glycemic control and diabetes complications.
- Analysis of pharmacokinetic and pharmacodynamic profiles of insulin preparations.
Main Results:
- Strict glycemic control significantly reduces acute and chronic diabetes complications.
- Newer insulin analogues, like Lispro (Humalog), offer improved pharmacokinetic profiles for mealtime insulin delivery.
Conclusions:
- Strict glycemic control is the primary goal of insulin therapy.
- Rapid-acting insulin analogues represent advancements in mimicking physiologic insulin secretion.
- Ongoing research aims to develop improved long-acting and hepatospecific insulin analogues.